Key result
Median daily step count measured by a wearable cardioverter-defibrillator correlated positively with 6-minute walk test distance at admission (r=0.32, p=0.04) and discharge (r=0.37, p=0.02).
Why the study?
It is unclear whether WCD-measured physical activity, step count, and heart rate correlate with established tools for cardiopulmonary fitness assessment such as the 6-min walk test.
Does WCD-measured daily step count correlate with 6-minute walk test distance in patients undergoing cardiac rehabilitation?
Observational (n=41)
No
Does WCD-measured daily step count correlate with 6-minute walk test distance in patients undergoing cardiac rehabilitation?
Effect estimate: r 0.32 (admission), r 0.37 (discharge)
p-value: p=0.04 (admission), 0.02 (discharge)
WCD-measured daily step count correlates positively with 6MWT distance, suggesting it could serve as a remote surrogate for cardiopulmonary exercise capacity.
WCD step counts correlate modestly with 6MWT; leaves open remote monitoring as surrogate for fitness in cardiac rehab.
Background: The wearable cardioverter–defibrillator (WCD) has a built-in accelerometer, which allows tracking of patients’ physical activity by remote monitoring. It is unclear whether WCD-measured physical activity, step count, and heart rate correlate with established tools for the assessment of cardiopulmonary fitness such as the 6-min walk test (6MWT). Objective: To correlate measurements of patient physical activity through the WCD with a supervised 6MWT during in-patient cardiac rehabilitation (CR) and to allow their use as surrogate parameters of cardiopulmonary fitness in an out-patient setting. Methods: Consecutive patients with a history of WCD use treated at our center and an in-patient CR following an index hospitalization were included. Baseline characteristics, measurements of WCD accelerometer (median daily step count, median daily activity level), median daily heart rate, and clinically supervised 6MWT at admission and discharge of CR were obtained. Results: Forty-one patients with a mean age of 55.5 (±11.5) years were included. Thirty-five patients (85.4%) were male and 28 patients (68%) had a primary prophylactic WCD-indication. The most common underlying heart diseases were ischemic heart disease (24 patients 58.6%) and dilated cardiomyopathy (13 patients, 31.7%). Median CR duration was 20 (IQR 19.75–26.25) days. 6MWT distance increased from a mean of 329 m (±107) to 470 m (±116) during CR (p < 0.0001). The median daily step count and activity level increased significantly, from 5542 steps (IQR 3718–7055) to 8778 (IQR 6229–12,920, p < 0.0001) and median 117 × 106 (IQR 96 × 106–142 × 106) threshold value exceedance (TVE) to 146 × 106 TVE (IQR 110 × 106–169 × 106, p < 0.0001), respectively. The median heart rate was 74.9 bpm (IQR 65.8–84.5) and 70.2 (IQR 64.1–77.3, p = 0.09) at admission and discharge, respectively. Of all three parameters, median daily step count showed the best correlation to the results of the 6MWT at admission and discharge (r = 0.32, p = 0.04 and 0.37, p = 0.02, respectively). Conclusions: Remote monitoring of median daily step count as assessed by the WCD’s accelerometer showed positive correlation with the 6MWT and could serve as a surrogate for cardiopulmonary exercise capacity. Assessment of daily step count and activity level measured remotely by the WCD could help to tailor optimal exercise instruction for patients not attending CR.
No takes yet. Share an insight, caveat, or question.
Kovacs et al. (2021) conducted an observational in Patients with a history of wearable cardioverter-defibrillator use undergoing cardiac rehabilitation (n=41). Wearable cardioverter-defibrillator (WCD) measured step count was evaluated on Correlation of median daily step count to the results of the 6-minute walk test (6MWT) at admission and discharge (r 0.32 (admission), r 0.37 (discharge), p=0.04 (admission), 0.02 (discharge)). Median daily step count measured by a wearable cardioverter-defibrillator correlated positively with 6-minute walk test distance at admission (r=0.32, p=0.04) and discharge (r=0.37, p=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: